SCHEMBL31661689

SCHEMBL31661689

O=C(O)CCCCC(=O)c1cc(F)ccc1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.53
CES1 P23141 3/20 0.53
DRD2 P14416 2/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
ALDH1A1 P00352 1/20 0.41
KEAP1 Q14145 1/20 0.41
POLB P06746 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5078142 1.00 CES2 (0.53) CES2CES1DRD2NPC1RAB9A
SCHEMBL5084694 0.89 CES2 (0.57) CES2CES1DRD2NPC1RAB9A
SCHEMBL13588197 0.84 CES2 (0.55) CES2CES1DRD2NPC1RAB9A
SCHEMBL28289421 0.84 CES2 (0.55) CES2CES1DRD2NPC1RAB9A
SCHEMBL29127613 0.83 CES2 (0.53) CES2CES1DRD2NPC1RAB9A
SCHEMBL29406527 0.83 CES2 (0.53) CES2CES1DRD2NPC1RAB9A
SCHEMBL15037828 0.83 CES2 (0.53) CES2CES1DRD2NPC1RAB9A
SCHEMBL28062364 0.83 HTR7 (0.59) CES2CES1DRD2NPC1RAB9A
Hydrochloric Acid SCHEMBL28432740 0.83 CES2 (0.53) CES2CES1DRD2NPC1RAB9A
SCHEMBL3220179 0.81 ACKR3 (0.51) CES2CES1DRD2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO claimed
WO-2025151884-A1 USE OF GLYCOSAMINOGLYCAN SULFATED POLYSACCHARIDES SUCH AS SODIUM PENTOSAN POLYSULFATE IN COMBINATION WITH PERMEATION AGENTS TO TREAT ALZHEIMER'S DISEASE PARSONS C LOWELL (US) 2025-07-17 WO disclosed